In a head-to-head trial against a full-strength GLP-1 drug, tirzepatide reduced food craving without changing measured restraint. Slower stomach emptying also makes smaller portions feel filling for longer. People whose eating was driven by stress, reward, or constant mental effort often describe the quiet as relief
AOD-9604 was developed to: Stimulate lipolysis (breakdown of stored fat) Inhibit lipogenesis (formation of new fat) Avoid raising IGF-1 levels Reduce impact on blood glucose Because it is a small fragment rather than the full hormone, it theoretically targets fat metabolism more specifically
Start Low, Titrate Slowly Every peptide protocol in this guide starts with a beginner dose
Athletes and competition AOD-9604 is on the World Anti-Doping Agency Prohibited List under category S2.2 (peptide hormones, growth factors, related substances, and mimetics)
They deliver B12 in a direct way that bypasses all barriers and gives quick results